A New Hope on the Horizon for Kidney and Cardiovascular Protection with SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Mineralocorticoid Receptor Antagonists in Type 2 Diabetic and Chronic Kidney Disease Patients

Metabolic Syndrome and Related Disorders, Ahead of Print.

Source: Metabolic Syndrome and Related Disorders - February 21, 2024 Category: Endocrinology Authors: Goce Spasovski Merita Rroji Goce Hristov Oliver Bushljetikj Nereida Spahia Irena Rambabova Bushletikj Source Type: research